Jayant Prakashrao Patil

Title: Inventor Jayant Prakashrao Patil: A Pioneer in Pharmaceutical Innovations

Introduction

Jayant Prakashrao Patil, an esteemed inventor based in Nasik, India, has made significant contributions to the field of pharmaceuticals. With a robust portfolio of two patents, he has been pivotal in advancing medical treatments, particularly in the area of diabetes management.

Latest Patents

Patil's latest patents demonstrate his innovative approach to pharmaceutical processes. The first patent is titled "Process for the preparation of teneligliptin," which outlines an efficient method for synthesizing this important medication used in treating type 2 diabetes. The second patent, "Amides of 2-amino-4-arylthiazole compounds and their salts," focuses on the preparation of salts of N-{4-[2,4-difluoro-3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl}dimethyl-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-5-yl)acetamide. This invention presents new formulations that hold potential for improving therapeutic efficacy.

Career Highlights

Throughout his career, Jayant Prakashrao Patil has held positions at notable companies. He has worked with Glenmark Pharmaceuticals Limited and Glenmark Pharmaceuticals S.A., contributing his expertise in the development of cutting-edge pharmaceutical solutions.

Collaborations

In his endeavor to innovate, Patil has collaborated with esteemed colleagues such as Suresh Mahadev Kadam and Bipin Parsottam Kansagra. These partnerships have fostered an environment of creativity and technological advancement, enhancing the potential impact of their collective research.

Conclusion

Jayant Prakashrao Patil's dedication to innovation in the pharmaceutical sector is evident through his patents and career achievements. His work not only aids in the development of critical medications but also highlights the importance of collaboration in driving medical advancements. As he continues to contribute to the field, Patil's inventions are sure to make a lasting impact on healthcare.